Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

Bullboard (TSXV:SBM)

View:
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
Comment by BradlTheGermanon May 01, 2023 3:41am

RE:RE:RE:RE:RE:What kills credibility

Well said. A bright future is ahead...Be smart and hold your positions for two more years. The reward can be explosive.
93
Discussion
Post by MirrorWorldManon Apr 30, 2023 11:56am

Moving Forward

"Sirona is currently engaging industry experts to determine the best path forward to commercialize TFC-1326." I am reassured that Howie et al does not see themselves as industry experts ...more  
233
Comment by forhandlarenon Apr 28, 2023 3:46pm

RE:RE:RE:RE:What kills credibility

Biotech investments are risky business compared to other industries. Usually very small gains short term, but suddenly one day down to line the reward can be anywhere between 10 and 100 times the ...more  
145
Discussion
Comment by emerald03on Apr 28, 2023 10:14am

RE:RE:RE:What kills credibility

I am basing price targets really only  on the Anti-aging product discounted . Once they decide their strategy, and if they go  with opening the data to any  and all interested parties ...more  
137
Discussion
Comment by emerald03on Apr 28, 2023 8:39am

RE:What kills credibility

Respectfully  I will say then  let's see what the share price is by  the by the end of 2023 ,and in 12 months too. .I will be happy to admit I was wrong if we are languishing below ...more  
85
Discussion
Comment by PeterGon Apr 28, 2023 8:28am

RE:What kills credibility

Good comment. A constant revenue stream will also stop further dilution. Hopefully.
62
Discussion
Comment by emerald03on Apr 28, 2023 7:08am

RE:RE:RE:13 going to hold?

I would base the  proposed rise   that xould be rapid on discounted cash flow in  the not too distant future fiscal years The cash flow could go towards the region of 50 to 100 ...more  
87
Discussion
Comment by forhandlarenon Apr 28, 2023 5:49am

RE:RE:RE:13 going to hold?

That's a good question PeterG. We have all various expectations on product sales in the end. I think this is a potential blockbuster meaning annual sales over 1 billion dollars. To some extent ...more  
96
Discussion
Comment by PeterGon Apr 28, 2023 4:54am

RE:RE:13 going to hold?

The question is if management prefers again an exclusive deal with a big partner or try to contract with many partners and regions. That's really interesting. Or Abbvie opens the casket and offer ...more  
70
Discussion
Comment by forhandlarenon Apr 28, 2023 12:33am

RE:RE:13 going to hold?

I'm sure that real competition will be lined up this time.  But I don't follow the proposed logic in respect of the share price. These companies will not buy a slice of Sirona and ...more  
120
Discussion
Comment by emerald03on Apr 27, 2023 11:20pm

RE:13 going to hold?

Buyers should be coming in soon as sellers dry up ,as way undervalued.. Those trial results were astounding ,those in pharma and medical field know it.Abbvie will now be so friendly to Sirona ,this ...more  
109
Discussion
Comment by LakeOromoctoon Apr 27, 2023 5:59pm

RE:RE:scrap one day scrap every day. Go back to $0.08

No need to promo these great results. The large companies are probably all ready abiding around. Does it matter if you can tell if it's great or not...... No!  We care what the Pharma ...more  
86
Discussion
Comment by Pareto8020on Apr 27, 2023 4:49pm

RE:scrap one day scrap every day. Go back to $0.08

No promo no leadership - no wonder this is still floundering around at a dime.
50
Discussion
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities